{"transactions":[{"id":1322669,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84809,"kind":"person","name":"Grove Janet P","position":1,"cik":"0001355675","reported_name":"Grove Janet P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T09:22:58.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest 100% on the one-year anniversary of the grant date (December 19, 2025) or immediately prior to the next Annual General Meeting, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":975,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":550},"source":{"system":"sec-edgar","filing":"0001213900-24-111558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355675/000121390024111558/ownership.xml","form_type":"4"}},{"id":1700000,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84809,"kind":"person","name":"Grove Janet P","position":1,"cik":"0001355675","reported_name":"Grove Janet P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T13:08:13.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest 100% on the one-year anniversary of the grant date (December 23, 2024) or immediately prior to the next Annual General Meeting, whichever is sooner."}],"balance_after":8500,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0001213900-23-098491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355675/000121390023098491/ownership.xml","form_type":"4"}},{"id":2081267,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84809,"kind":"person","name":"Grove Janet P","position":1,"cik":"0001355675","reported_name":"Grove Janet P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T16:54:02.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":1400,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":840},"source":{"system":"sec-edgar","filing":"0001213900-22-080969","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355675/000121390022080969/ownership.xml","form_type":"4"}},{"id":2381747,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":84809,"kind":"person","name":"Grove Janet P","position":1,"cik":"0001355675","reported_name":"Grove Janet P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-22T20:16:17.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 02/18/2022 with 390 stock options vesting on the 18th day of each of the 35 months commencing March 18, 2022 through January 18, 2025 and 350 stock options will vest on February 18, 2025."}],"balance_after":14000,"derivative":{"exercise_price":1.12,"expiration_date":"2027-02-17","underlying":"Common shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001213900-22-008775","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355675/000121390022008775/ownership.xml","form_type":"4"}}]}